Alpine Global Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,000
| Closed | -$219K | – | 248 |
|
|
2024
Q3 | $219K | Sell |
10,000
-19,149
| -66% | -$419K | 0.05% | 130 |
|
|
2024
Q2 | $227K | Sell |
29,149
-5,851
| -17% | -$45.6K | 0.04% | 286 |
|
|
2024
Q1 | $145K | Buy |
35,000
+5,000
| +17% | +$20.7K | 0.03% | 174 |
|
|
2023
Q4 | $78.3K | Hold |
30,000
| – | – | 0.02% | 169 |
|
|
2023
Q3 | $56.1K | Hold |
30,000
| – | – | 0.01% | 143 |
|
|
2023
Q2 | $75.3K | Sell |
30,000
-115,000
| -79% | -$289K | 0.02% | 178 |
|
|
2023
Q1 | $254K | Sell |
145,000
-57,928
| -29% | -$101K | 0.1% | 74 |
|
|
2022
Q4 | $862K | Buy |
+202,928
| New | +$862K | 0.29% | 37 |
|
|
2022
Q3 | – | Sell |
-300,000
| Closed | -$300K | – | 494 |
|
|
2022
Q2 | $300K | Buy |
+300,000
| New | +$300K | 0.08% | 102 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 118 |
|